X0202 SCHEDULE 13G/A 0001132317 XXXXXXXX LIVE 1 Common Stock, $0.0001 par value per share 06/30/2026 0001763950 Lantern Pharma Inc. 51654W101 1920 McKinney Avenue, 7th Floor Dallas TX 75201 Rule 13d-1(c) Thomas A. Satterfield, Jr. X1 95000.00 880000.00 95000.00 880000.00 975000.00 N 7.6 IN *Based on (i) 11,304,697 shares of common stock of the issuer (the "Common Stock") outstanding as of May 12, 2026, as reported by the issuer in its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 and (ii) the sale of an additional 1,454,175 shares of Common Stock as reported by the issuer in its Current Report on Form 8-K filed May 14, 2026. Lantern Pharma Inc. 1920 McKinney Avenue, 7th Floor, Dallas, TX 75201 Thomas A. Satterfield, Jr. 15 Colley Cove Drive Gulf Breeze, Florida 32561 Incorporated by reference from Item 4 of the Cover Page. Y Incorporated by reference from Item 9 of the Cover Page. Incorporated by reference from Item 11 of the Cover Page. Incorporated by reference from Item 5 of the Cover Page. Incorporated by reference from Item 6 of the Cover Page. Incorporated by reference from Item 7 of the Cover Page. Incorporated by reference from Item 8 of the Cover Page. Y N With respect to the beneficial ownership reported for Thomas A. Satterfield, Jr., 25,000 shares are held jointly with Rebecca S. Satterfield, Mr. Satterfield's spouse; 100,000 shares are held by Tomsat Investment & Trading Co., Inc., a corporation controlled by Mr. Satterfield and of which he serves as President; 500,000 shares are held by Caldwell Mill Opportunity Fund, LLC which fund is managed by an entity of which Mr. Satterfield owns a 50% interest and serves as Chief Investment Manager; and 250,000 shares are held by A.G. Family L.P., a partnership managed by a general partner controlled by Mr. Satterfield. Additionally, Mr. Satterfield has limited power of attorney for voting and disposition purposes with respect to 5,000 shares held by Rebecca S. Satterfield. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Thomas A. Satterfield, Jr. /s/ Thomas A. Satterfield, Jr. 07/23/2026